| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anticoagulation practice patterns in COVID‐19: A global survey
|
Rosovsky, Rachel P.
|
|
|
4 |
6 |
p. 969-983
|
artikel
|
| 2 |
Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
|
Hald, Erin Mathiesen
|
|
|
4 |
6 |
p. 1004-1012
|
artikel
|
| 3 |
Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
|
Favaloro, Emmanuel J.
|
|
|
4 |
6 |
p. 952-957
|
artikel
|
| 4 |
Desmopressin responsiveness by age in type 1 von Willebrand disease
|
Goldberg, Nicola
|
|
|
4 |
6 |
p. 1046-1052
|
artikel
|
| 5 |
Essential aspects of the follow‐up after acute pulmonary embolism: An illustrated review
|
Boon, Gudula J.A.M.
|
|
|
4 |
6 |
p. 958-968
|
artikel
|
| 6 |
Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blotting
|
Rosell, Axel
|
|
|
4 |
6 |
p. 1013-1023
|
artikel
|
| 7 |
Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity
|
Wang, Michael
|
|
|
4 |
6 |
p. 1035-1045
|
artikel
|
| 8 |
High‐dose IVIG plus cangrelor platelet “anesthesia” during urgent heparin‐CPB in a patient with recent SRA‐negative HIT‐thrombosis with persisting platelet‐activating antibodies
|
Koster, Andreas
|
|
|
4 |
6 |
p. 1060-1064
|
artikel
|
| 9 |
Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
|
Vangenechten, Inge
|
|
|
4 |
6 |
p. 1024-1034
|
artikel
|
| 10 |
ISSUE INFORMATION
|
|
|
|
4 |
6 |
p. 947-951
|
artikel
|
| 11 |
Rate zonal centrifugation can partially separate platelets from platelet‐derived vesicles
|
Rikkert, Linda G.
|
|
|
4 |
6 |
p. 1053-1059
|
artikel
|
| 12 |
Reply to a letter from Jackson J et al: Effect of pH on thrombin activity measured by calibrated automated thrombinography
|
Kristensen, Søren Risom
|
|
|
4 |
6 |
p. 1065
|
artikel
|
| 13 |
Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
|
Riker, Richard R.
|
|
|
4 |
6 |
p. 1068-1069
|
artikel
|
| 14 |
Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID‐19: Study design of the phase IIa STARS trial
|
Moore, Hunter B.
|
|
|
4 |
6 |
p. 984-996
|
artikel
|
| 15 |
The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
|
May, Jori E.
|
|
|
4 |
6 |
p. 1066-1067
|
artikel
|
| 16 |
Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy
|
Yuen, Hiu Lam Agnes
|
|
|
4 |
6 |
p. 997-1003
|
artikel
|
Tijdschrift beschrijving